1-6 of 6
Gerard M. J. Bos
Close
Sort by
Journal Articles

Phase 1/2 study of lenalidomide combined with low-dose cyclophosphamide and prednisone in lenalidomide-refractory multiple myeloma

Clinical Trials & Observations
Inger S. Nijhof, Laurens E. Franssen, Mark-David Levin, Gerard M. J. Bos, Annemiek Broijl, Saskia K. Klein, Harry R. Koene, Andries C. Bloem, Aart Beeker, Laura M. Faber, Ellen van der Spek, Paula F. Ypma, Reinier Raymakers, Dick-Johan van Spronsen, Peter E. Westerweel, Rimke Oostvogels, Jeroen van Velzen, Berris van Kessel, Tuna Mutis, Pieter Sonneveld, Sonja Zweegman, Henk M. Lokhorst, Niels W. C. J. van de Donk
Journal: Blood
Blood (2016) 128 (19): 2297–2306.
https://doi.org/10.1182/blood-2016-07-729236
Published: 2016
Includes: Supplemental data
Journal Articles

Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma

Clinical Trials & Observations
Sonja Zweegman, Bronno van der Holt, Ulf-Henrik Mellqvist, Morten Salomo, Gerard M. J. Bos, Mark-David Levin, Heleen Visser-Wisselaar, Markus Hansson, Annette W. G. van der Velden, Wendy Deenik, Astrid Gruber, Juleon L. L. M. Coenen, Torben Plesner, Saskia K. Klein, Bea C. Tanis, Damian L. Szatkowski, Rolf E. Brouwer, Matthijs Westerman, M. (Rineke) B. L. Leys, Harm A. M. Sinnige, Einar Haukås, Klaas G. van der Hem, Marc F. Durian, E. (Vera) J. M. Mattijssen, Niels W. C. J. van de Donk, Marian J. P. L. Stevens-Kroef, Pieter Sonneveld, Anders Waage
Journal: Blood
Blood (2016) 127 (9): 1109–1116.
https://doi.org/10.1182/blood-2015-11-679415
Published: 2016
Includes: Supplemental data
Journal Articles

Inflammation restraining effects of prostaglandin E2 on natural killer–dendritic cell (NK-DC) interaction are imprinted during DC maturation

Catharina H. M. J. Van Elssen, Joris Vanderlocht, Tammy Oth, Birgit L. M. G. Senden-Gijsbers, Wilfred T. V. Germeraad, Gerard M. J. Bos
Journal: Blood
Blood (2011) 118 (9): 2473–2482.
https://doi.org/10.1182/blood-2010-09-307835
Published: 2011
Includes: Supplemental data
Journal Articles

In vitro–differentiated T/natural killer–cell progenitors derived from human CD34 + cells mature in the thymus

Brief Report
Bob Meek, Silvie Cloosen, Chiara Borsotti, Catharina H. M. J. Van Elssen, Joris Vanderlocht, Melanie C. A. Schnijderberg, Marjolein W. M. van der Poel, Bas Leewis, Reinout Hesselink, Markus G. Manz, Yoshimoto Katsura, Hiroshi Kawamoto, Wilfred T. V. Germeraad, Gerard M. J. Bos
Journal: Blood
Blood (2010) 115 (2): 261–264.
https://doi.org/10.1182/blood-2009-05-223990
Published: 2010
Includes: Supplemental data
Journal Articles

Response: Homocysteine lowering and recurrent venous thrombosis: the VITRO trial

Martin den Heijer, Henk J. Blom, Frits R. Rosendaal, Gerard M. J. Bos
Journal: Blood
Blood (2007) 109 (12): 5521–5522.
https://doi.org/10.1182/blood-2007-02-075507
Published: 2007
Journal Articles

Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: a randomized, placebo-controlled, double-blind trial

Clinical Trials & Observations
Martin den Heijer, Huub P. J. Willems, Henk J. Blom, Wim B. J. Gerrits, Marco Cattaneo, Sabine Eichinger, Frits R. Rosendaal, Gerard M. J. Bos
Journal: Blood
Blood (2006) 109 (1): 139–144.
https://doi.org/10.1182/blood-2006-04-014654
Published: 2006